Multiple antibody specificities (gp41, V1V2, and V3) elicited in the phase II multiclade (A, B, C) HIV-1 DNA prime, rAd5 boost vaccine trial.
| Autor: | Williams, W. B.1, Jones, K.1, Krambrink, A.2, Grove, D.2, Liu, P.1, Yates, N. L.1, Moody, M. A.1, Ferrari, G.1, Pollara, J.1, Moodie, Z.2, Morgan, C. A.2, H. Liao1, Montefiori, D. C.1, Ochsenbauer, C.3, Kappes, J.3, Hammer, S.4, Mascola, J.5, Koup, R.5, Corey, L.6, Nabel, G.5 |
|---|---|
| Zdroj: | Retrovirology. 2012 Supplement, Vol. 9 Issue Suppl 2, p1-1. 1p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|